Cargando…
Efficacy of intravenous immunoglobulins (IVIG) in COVID-19 patients: a systematic review and meta-analysis
BACKGROUND AND PURPOSE: Though controversial, many clinical trials have been conducted to evaluate the efficacy of intravenous immunoglobulins (IVIG) in COVID-19 cases. Therefore, a systematic review and meta-analysis have been performed to evaluate the efficacy of IVIG in the treatment of COVID-19...
Autores principales: | Fatemi, Behzad, Rezaei, Soheila, Peikanpour, Mohammad, Dastan, Farzaneh, Saffaei, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443666/ https://www.ncbi.nlm.nih.gov/pubmed/37614613 http://dx.doi.org/10.4103/1735-5362.378082 |
Ejemplares similares
-
Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
por: Tabarsi, Payam, et al.
Publicado: (2021) -
Efficacy of IVIG (intravenous immunoglobulin) for corona virus disease 2019 (COVID-19): A meta-analysis
por: Xiang, Huai-rong, et al.
Publicado: (2021) -
Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19
por: Pourahmad, Ramtin, et al.
Publicado: (2020) -
Intravenous Immunoglobulins: Evolution of Commercial IVIG Preparations
por: Hooper, John A.
Publicado: (2008) -
Intravenous immunoglobulins (IVIG) in severe/critical COVID-19 adult patients
por: Kwapisz, Dorota, et al.
Publicado: (2023)